118 related articles for article (PubMed ID: 26732495)
21. Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy.
Tang Y; Liu B; Li J; Wu H; Yang J; Zhou X; Yi M; Li Q; Yu S; Yuan X
Cancer Med; 2016 Jan; 5(1):24-32. PubMed ID: 26645682
[TBL] [Abstract][Full Text] [Related]
22. Genetic variants in the ITGB6 gene is associated with the risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.
Yi M; Tang Y; Liu B; Li Q; Zhou X; Yu S; Fu S; Cai Y; Yuan X
Tumour Biol; 2016 Mar; 37(3):3469-77. PubMed ID: 26449830
[TBL] [Abstract][Full Text] [Related]
23. Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.
Tucker SL; Li M; Xu T; Gomez D; Yuan X; Yu J; Liu Z; Yin M; Guan X; Wang LE; Wei Q; Mohan R; Vinogradskiy Y; Martel M; Liao Z
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):251-7. PubMed ID: 22541966
[TBL] [Abstract][Full Text] [Related]
24. The Plasma Levels and Polymorphisms of Vitronectin Predict Radiation Pneumonitis in Patients With Lung Cancer Receiving Thoracic Radiation Therapy.
Yu JH; Zhao QY; Liu Y; Zhu XR; Yang ZR; Fu XL; Cai XW
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):757-765. PubMed ID: 33610390
[TBL] [Abstract][Full Text] [Related]
25. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4.
Bergholdt R; Taxvig C; Eising S; Nerup J; Pociot F
J Leukoc Biol; 2005 Apr; 77(4):579-85. PubMed ID: 15629882
[TBL] [Abstract][Full Text] [Related]
26. Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
Zheng Y; Shi A; Wang W; Yu H; Yu R; Li D; Xu B; Ma H; You J; Zhao D; Jiang L; Geng J; Zhu G
Clin Lung Cancer; 2018 Jul; 19(4):e399-e404. PubMed ID: 29519614
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
[TBL] [Abstract][Full Text] [Related]
28. The association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer.
Jiang C; Guo Y; Li Y; Kang J; Sun X; Wu H; Feng J; Xu Y
J Thorac Dis; 2021 May; 13(5):3126-3136. PubMed ID: 34164203
[TBL] [Abstract][Full Text] [Related]
29. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
[TBL] [Abstract][Full Text] [Related]
30. Single-nucleotide polymorphisms of TGFβ1 and ATM associated with radiation-induced pneumonitis: a prospective cohort study of thoracic cancer patients in China.
Xiao Y; Yuan X; Qiu H; Li Q
Int J Clin Exp Med; 2015; 8(9):16403-13. PubMed ID: 26629166
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants in the plasminogen activator inhibitor-1 gene are associated with an increased risk of radiation pneumonitis in lung cancer patients.
Liu B; Tang Y; Yi M; Liu Q; Xiong H; Hu G; Yuan X
Cancer Med; 2017 Mar; 6(3):681-688. PubMed ID: 28211612
[TBL] [Abstract][Full Text] [Related]
32. The CBLB gene and Graves' disease in children.
Chen CC; Huang CY; Huang FY; Dang CW; Lin CL; Lo FS; Lin CH; Tsang CC; Li HJ; Liu HF; Chu CC; Lin M; Lee YJ
J Pediatr Endocrinol Metab; 2005 Nov; 18(11):1119-26. PubMed ID: 16459459
[TBL] [Abstract][Full Text] [Related]
33. Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancer.
Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Komaki R; Hu Y; Hahn SM; Liao Z
Cancer Med; 2018 Jun; 7(6):2247-2255. PubMed ID: 29745043
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
35. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
36. Association between ATM gene polymorphisms, lung cancer susceptibility and radiation-induced pneumonitis: a meta-analysis.
Yan Z; Tong X; Ma Y; Liu S; Yang L; Yang X; Yang X; Bai M; Fan H
BMC Pulm Med; 2017 Dec; 17(1):205. PubMed ID: 29246212
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
Lee YH; Choi HS; Jeong H; Kang KM; Song JH; Lee WS; Lee GW; Song HN; Kim HG; Kang MH; Rhee DY; Jeong BK
Clin Respir J; 2018 Mar; 12(3):1264-1273. PubMed ID: 28618180
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer.
Song SY; Jeong SY; Park HJ; Park SI; Kim DK; Kim YH; Shin SS; Lee SW; Ahn SD; Kim JH; Lee JS; Choi EK
Lung Cancer; 2010 May; 68(2):278-82. PubMed ID: 19596483
[TBL] [Abstract][Full Text] [Related]
39. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.
Li R; Gu J; Heymach JV; Shu X; Zhao L; Han B; Ye Y; Roth J; Wu X
Carcinogenesis; 2017 Apr; 38(4):419-424. PubMed ID: 28186269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
